Glucotrack (GCTK) Other financing activities (2013 - 2024)

Glucotrack (GCTK) posted Other financing activities of -$400000.0 for Q4 2024, down 80708.08% on a QoQ basis from -$495.0 in Q4 2019.

Glucotrack (GCTK) Other financing activities (2013 - 2024) Analysis & Trends

Glucotrack's Other financing activities history runs 4 years deep, the most recent figure standing at -$400000.0 for Q4 2024.

Quarterly Other financing activities changed N/A year-over-year to -$400000.0 in Q4 2024, while the trailing twelve-month figure through Dec 2024 was -$400495.0 (changed N/A YoY) and the FY2025 annual result came in at $3.5 million, up 3444.0% from the prior year.
Other financing activities was -$400000.0 for Q4 2024 at Glucotrack, down from -$495.0 in the prior quarter.
Across five years, Other financing activities topped out at -$400000.0 in Q4 2024 and bottomed at -$400000.0 in Q4 2024.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Alcon	32,734,969.19 Bn	32,734,967.53 Bn	1.53 Bn
2	Intuitive Surgical	117.50 Bn	112.41 Bn	1.96 Bn
3	Becton Dickinson	42.93 Bn	42.11 Bn	2.15 Bn
4	Medline	30.82 Bn	36.66 Bn	1.84 Bn
5	Resmed	27.90 Bn	26.23 Bn	890.98 Mn
6	West Pharmaceutical Services	26.76 Bn	26.23 Bn	329.20 Mn
7	Cooper Companies	15.30 Bn	15.16 Bn	735.40 Mn
8	Solventum	13.46 Bn	12.90 Bn	1.10 Bn
9	Align Technology	12.02 Bn	10.96 Bn	736.59 Mn
10	Glucotrack	33.48	-7.38 Mn	-

Download Data